Reported 10 days ago
Billionaire investor Ken Fisher highlights Johnson & Johnson (JNJ) as a strong defensive stock in his investment portfolio. With a beta value of 0.41 and a dividend yield of 3.24%, JNJ has consistently demonstrated robustness in its healthcare sector business, even amidst challenges like recent legal issues. Fisher believes that value stocks, particularly in European markets, will outperform growth stocks this year, indicating a shift in market dynamics.
Source: YAHOO